VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)
$14.28 -0.4 (-2.7248%)
Analysed VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) News Sources
Kopp Family Office Trims $3.5 Million Worth of Viridian Therapeutics Stake -- What Investors Should Know
21-04-2026
fool.com
Analysts Have Just Cut Their Viridian Therapeutics, Inc. (NASDAQ:VRDN) Revenue Estimates By 20%
21-04-2026
yahoo.com
Truist Cuts PT on Viridian Therapeutics (VRDN) to $36 From $40
20-04-2026
yahoo.com
Evercore ISI Adjusts Viridian Therapeutics, Inc. (VRDN) Outlook in Pre-Earnings Preview
17-04-2026
yahoo.com
Viridian Therapeutics price target lowered to $36 from $40 at Truist
09-04-2026
yahoo.com
A Look At Viridian Therapeutics (VRDN) Valuation After A Sharp Multi‑Month Share Price Pullback
08-04-2026
yahoo.com
Stifel sees path towards differentiation for Viridian after Amgen data
07-04-2026
yahoo.com
AMGN's Subcutaneous Tepezza Scores Phase III Win in Thyroid Eye Disease
07-04-2026
yahoo.com
Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study.
06-04-2026
yahoo.com
Amgen Unveils Upbeat Results For Tepezza After Rival Eye Disease Drug Disappoints
06-04-2026
yahoo.com
What is the current price of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?
The current price of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is $14.28.
VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) since the previous trading day is $-0.4.
VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) since the previous trading day is -2.7248%.
What is the most recent average sentiment score for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?
The most recent average sentiment score for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?
The most recent sentiment for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is .
SEC-8K** Filing Available For VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.